3C
MED icon

361 Capital’s Medifast MED Stock Holding History

361 Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,518
Closed -$1.3M – 373
2019
Q3 		$1.3M Sell
12,518
-284
-2% -$30.5K 0.24% 182
2019
Q2 		$1.64M Sell
12,802
-906
-7% -$126K 0.29% 172
2019
Q1 		$1.75M Buy
13,708
+1,108
+9% +$141K 0.3% 168
2018
Q4 		$1.57M Buy
12,600
+5,295
+72% +$906K 0.32% 172
2018
Q3 		$1.62M Sell
7,305
-2,330
-24% -$472K 0.35% 154
2018
Q2 		$1.54M Sell
9,635
-6,585
-41% -$842K 0.35% 168
2018
Q1 		$1.52M Sell
16,220
-3,312
-17% -$247K 0.38% 112
2017
Q4 		$1.36M Buy
+19,532
New +$1.3M 0.34% 160

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

361 Capital's MED Position: Q4 2019 in Review

361 Capital sold out of Medifast (MED) in Q4 2019, closing a stake of 12,518 shares — an estimated $1.3M sold.

361 Capital first reported a position in MED in Q4 2017 and held it in 8 quarters. The position peaked at $1.75M in Q1 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • 361 Capital reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • 361 Capital sold 12,518 Medifast shares in Q4 2019, an estimated $1.3M.
  • 361 Capital first reported a position in Medifast in Q4 2017 and held it in 8 quarters.
  • 361 Capital's Medifast position peaked at $1.75M in Q1 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on 361 Capital's 13F filing for Q4 2019, filed 13 Feb 2020.